Response to the letter: Hyperprogression in advanced melanoma is not restricted to immunotherapy

Eur J Cancer. 2024 Mar:200:113562. doi: 10.1016/j.ejca.2024.113562. Epub 2024 Jan 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Disease Progression
  • Humans
  • Immunotherapy
  • Melanoma* / drug therapy